Literature DB >> 29025618

Preventing tuberculosis in people with HIV-no more excuses.

Richard E Chaisson1, Jonathan E Golub2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29025618      PMCID： PMC6352306          DOI： 10.1016/S2214-109X(17)30390-X

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  8 in total

Review 1.  Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration.

Authors:  Nicole Salazar-Austin; David W Dowdy; Richard E Chaisson; Jonathan E Golub
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

2.  One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.

Authors:  Susan Swindells; Ritesh Ramchandani; Amita Gupta; Constance A Benson; Jorge Leon-Cruz; Noluthando Mwelase; Marc A Jean Juste; Javier R Lama; Javier Valencia; Ayotunde Omoz-Oarhe; Khuanchai Supparatpinyo; Gaerolwe Masheto; Lerato Mohapi; Rodrigo O da Silva Escada; Sajeeda Mawlana; Peter Banda; Patrice Severe; James Hakim; Cecilia Kanyama; Deborah Langat; Laura Moran; Janet Andersen; Courtney V Fletcher; Eric Nuermberger; Richard E Chaisson
Journal:  N Engl J Med       Date:  2019-03-14       Impact factor: 91.245

3.  Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis.

Authors:  Juan F Vesga; Christian Lienhardt; Placide Nsengiyumva; Jonathon R Campbell; Olivia Oxlade; Saskia den Boon; Dennis Falzon; Kevin Schwartzman; Gavin Churchyard; Nimalan Arinaminpathy
Journal:  BMC Med       Date:  2022-05-18       Impact factor: 11.150

4.  Brief Report: Yield of Repeat Tuberculin Skin Testing for People Living With HIV in Brazil.

Authors:  Lelia H Chaisson; Valeria Saraceni; Silvia Cohn; Solange C Cavalcante; Richard E Chaisson; Betina Durovni; Jonathan E Golub
Journal:  J Acquir Immune Defic Syndr       Date:  2021-12-01       Impact factor: 3.771

Review 5.  Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB.

Authors:  Elisa H Ignatius; Susan Swindells
Journal:  Curr HIV/AIDS Rep       Date:  2020-12       Impact factor: 5.495

6.  Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial.

Authors:  Peter MacPherson; Limakatso Lebina; Kegaugetswe Motsomi; Zama Bosch; Minja Milovanovic; Andrew Ratsela; Sanjay Lala; Ebrahim Variava; Jonathan E Golub; Emily L Webb; Neil A Martinson
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

Review 7.  Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection.

Authors:  Kevin Wong; James Nguyen; Lillie Blair; Marina Banjanin; Bunraj Grewal; Shane Bowman; Hailey Boyd; Grant Gerstner; Hyun Jun Cho; David Panfilov; Cho Ki Tam; Delaney Aguilar; Vishwanath Venketaraman
Journal:  J Clin Med       Date:  2020-11-06       Impact factor: 4.241

Review 8.  Child Contact Case Management-A Major Policy-Practice Gap in High-Burden Countries.

Authors:  Anca Vasiliu; Nicole Salazar-Austin; Anete Trajman; Trisasi Lestari; Godwin Mtetwa; Maryline Bonnet; Martina Casenghi
Journal:  Pathogens       Date:  2021-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.